141 related articles for article (PubMed ID: 6488784)
21. Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing.
Sasseville D
Contact Dermatitis; 2001 Oct; 45(4):232-3. PubMed ID: 11683835
[No Abstract] [Full Text] [Related]
22. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
[TBL] [Abstract][Full Text] [Related]
23. Hydrocortisone: an important cutaneous allergen.
Wilkinson SM; Cartwright PH; English JS
Lancet; 1991 Mar; 337(8744):761-2. PubMed ID: 1672393
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
Shaw DW; Maibach HI
Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
[TBL] [Abstract][Full Text] [Related]
25. Topical corticosteroid allergy in an urban Australian centre.
Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
[TBL] [Abstract][Full Text] [Related]
26. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
Bruze M; Bjorkner B; Dooms-Goossens A
Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
[TBL] [Abstract][Full Text] [Related]
27. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
[TBL] [Abstract][Full Text] [Related]
28. Contact dermatitis from amlexanox eyedrops.
Yamashita H; Kawashima M
Contact Dermatitis; 1991 Oct; 25(4):255-6. PubMed ID: 1839268
[No Abstract] [Full Text] [Related]
29. Tixocortol pivalate: what is the right concentration?
Kalavala M; Statham BN; Green CM; King C; Ormerod AD; Sansom J; English JS; Wilkinson MS; Horne H; Gawkrodger D
Contact Dermatitis; 2007 Jul; 57(1):44-6. PubMed ID: 17577357
[TBL] [Abstract][Full Text] [Related]
30. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
[No Abstract] [Full Text] [Related]
31. Allergic contact dermatitis due to highly reactive halogenated compounds.
Pickering FC; Ive FA
Contact Dermatitis; 1983 Nov; 9(6):500-3. PubMed ID: 6228379
[TBL] [Abstract][Full Text] [Related]
32. Allergic contact dermatitis from tobramycin.
Menéndez Ramos F; Llamas Martín R; Zarco Olivo C; Dorado Bris JM; Merino Luque MV
Contact Dermatitis; 1990 May; 22(5):305-6. PubMed ID: 2143453
[No Abstract] [Full Text] [Related]
33. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
Gönül M; Gül U
Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
[TBL] [Abstract][Full Text] [Related]
34. [An unrecognized cause of allergic eczema of the face: a corticoid, tixocortol pivalate].
Foussereau J; Jelen G
Presse Med; 1987 May; 16(17):832. PubMed ID: 2954110
[No Abstract] [Full Text] [Related]
35. Systemic contact dermatitis caused by systemic corticosteroid use.
Murata Y; Kumano K; Ueda T; Araki N; Nakamura T; Tani M
Arch Dermatol; 1997 Aug; 133(8):1053-4. PubMed ID: 9267261
[No Abstract] [Full Text] [Related]
36. Probable active sensitization to tixocortol pivalate.
Goldsmith PC; White IR; Rycroft RJ; McFadden JP
Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
[No Abstract] [Full Text] [Related]
37. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014.
Pratt MD; Mufti A; Lipson J; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Zirwas MJ; Fransway AF; Mathias CG; Zug KA; DeLeo VA; Fowler JF; Marks JG; Storrs FJ; Belsito DV
Dermatitis; 2017; 28(1):58-63. PubMed ID: 28002236
[TBL] [Abstract][Full Text] [Related]
38. Contact dermatitis from propolis: role of gastrointestinal absorption.
Trevisan G; Kokelj F
Contact Dermatitis; 1987 Jan; 16(1):48. PubMed ID: 3816213
[No Abstract] [Full Text] [Related]
39. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
Mirshahpanah P; Maibach HI
Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
[TBL] [Abstract][Full Text] [Related]
40. Sensitization to chloramphenicol; a persistent problem.
van Joost T; Dikland W; Stolz E; Prens E
Contact Dermatitis; 1986 Mar; 14(3):176-8. PubMed ID: 3709162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
